Imunon, Inc.
IMNN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000749647
In the last 90 days, Imunon, Inc. insiders filed 0 open-market purchases and 5 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $506.1K in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Imunon, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 25 | 22 | −3 |
| Shares | 919.6K | 488.7K | −430.8K (−46.9%) |
| Value | $1.69M | $818.1K | −$868.0K (−51.5%) |
New holders (2)
Institutions that held Imunon, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 32,047 | $54.0K | 0.00% |
| Virtu Financial LLC | 10,934 | $18.0K | 0.00% |
Sold out (5)
Institutions that held Imunon, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Murchinson Ltd. | 276,644 | $509.0K |
| Susquehanna International Group, LLP | 52,274 | $95.0K |
| Two Sigma Investments, LP | 19,883 | $37.0K |
| Citigroup Inc | 11,194 | $20.0K |
| Gradient Investments LLC | 14 | $0 |